Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.
about
Pharmacotherapy and airway remodelling in asthma?Effects of terbutaline on NGF formation in allergic inflammation of the ratInteractions between corticosteroids and beta-adrenergic agonists in asthma disease induction, progression, and exacerbation.Desensitization of beta2-adrenoceptor-mediated responses by short-acting beta2-adrenoceptor agonists in human lung mast cells.Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.Influence of agonist intrinsic activity on the desensitisation of beta2-adrenoceptor-mediated responses in mast cells.Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulationComparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.The mast cell and allergic diseases: role in pathogenesis and implications for therapy.The long-acting beta-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells.Budesonide/formoterol dry powder in asthma: an option for control as maintenance and reliever therapy.Beta-adrenergic agonists inhibit corticosteroid-induced apoptosis of airway epithelial cells.A steroid-mimicking nanomaterial that mediates inhibition of human lung mast cell responsesCharacterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.Salmeterol, a beta2-receptor agonist, attenuates lipopolysaccharide-induced lung inflammation in mice.Assessing immunotoxicity of pharmaceuticals: the need for enhanced testing.Effect of salbutamol on nasal symptoms and mast cell degranulation induced by adenosine 5' monophosphate nasal challenge.TRAIL deficiency and PP2A activation with salmeterol ameliorates egg allergen-driven eosinophilic esophagitis.Adrenergic Signaling at the Interface of Allergic Asthma and Viral Infections.
P2860
Q24678822-77EFBE56-95A9-4660-BB09-0C6AFD34479FQ28363872-035CA6EF-A14C-4D6B-A5F8-AB6DE2B42B47Q33860283-F41B2399-FE60-42EA-B583-42C43BD7C617Q35044948-8DB07DBE-92EC-4992-A3CD-90ED9BE4682BQ35046032-854D6400-2061-4634-87EA-A11819E55644Q35047601-8FC6C730-9B91-4599-B996-F0549087AF14Q35545787-75A4CC1D-F0B0-40A7-944D-CC5C63E7F9F7Q35825799-3C939ADF-156F-4501-AF84-6EDD326880FEQ37010493-BEA7FC6F-7F15-41BD-9295-2F2E5C4E3E75Q37481301-B548534A-AABB-45B0-9686-EFE5BCF2AB53Q37678433-26FA0D34-CFB4-4FE0-8B30-9FDF5760F2DCQ40650227-AB7FDDC8-D22C-4FD7-99E7-928DBA06CC6DQ42543826-1127AD88-3EFF-4C38-AC8F-EC3DE036FFBAQ42710611-3788C91B-D8C8-48ED-89CD-1F152F42D178Q44732744-E24349D8-AED6-4FB4-98EE-685E2FA67A9AQ46504576-1C20904E-B0B4-447F-A3D6-571EFBC0F434Q46704685-DC5F509B-A680-4EAB-99CB-D95A6B3C850BQ47806901-128863A0-3AA2-4EA5-94E3-5FBF8CEC56D3Q52562639-269CD2A7-44F8-4442-9D9B-B9F336B1C6F9
P2860
Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Salmeterol inhibition of media ...... nt and independent mechanisms.
@ast
Salmeterol inhibition of media ...... nt and independent mechanisms.
@en
type
label
Salmeterol inhibition of media ...... nt and independent mechanisms.
@ast
Salmeterol inhibition of media ...... nt and independent mechanisms.
@en
prefLabel
Salmeterol inhibition of media ...... nt and independent mechanisms.
@ast
Salmeterol inhibition of media ...... nt and independent mechanisms.
@en
P2093
P2860
P356
P1476
Salmeterol inhibition of media ...... nt and independent mechanisms.
@en
P2093
C J Vardey
P T Peachell
P2860
P304
P356
10.1038/SJ.BJP.0701703
P407
P577
1998-03-01T00:00:00Z